Quit Genius logo

Quit Genius Funding & Investors

Quit Genius is the world’s first digital clinic for treating nicotine, alcohol and opioid addictions. Built on the evidence-based approach of Medication-Assisted Treatment (MAT), Quit Genius combines virtual cognitive behavioral therapy (CBT) with approved medication and connected devices to help employers and health plans tackle the high cost of addiction, while improving the lives of their employees and members.

quitgenius.com

Total Amount Raised: $78,600,000

Quit Genius Funding Rounds

  • Series B

    $64,000,000

    Series B Investors

    Triple Point
    Startup Health
    Healthcare Co-op
    Atomico
    Octopus Ventures
    Kinnevik
  • Series A

    $12,000,000

    Series A Investors

    Triple Point
    Burda Principal Investments
    Startup Health
    Venus Williams
    Cur8 Capital
    Y Combinator
    Octopus Ventures
    Serena Ventures
  • Seed

    $2,600,000

    Seed Investors

    Village Global
    AAF Management
    Max Mullen
    Pioneer Fund
    Force Over Mass Capital
    Olivia Teich
    Juha Paananen
    Merck
    Y Combinator
    Junaid Bajwa
    Telefónica
    David Langer
    Paul Rosania
    Eric Ries
    EQT Ventures
    Lionheart Ventures
Funding info provided by Diffbot.